SÃO PAULO, BRAZIL - The Butantan Institute will receive the first five million doses of the Coronavac vaccine against Covid-19, from the Chinese manufacturer Sinovac, in the coming days. The vaccine is in phase 3 trials, the last stage required before its approval, but the government of São Paulo has already secured the importation of 46 million doses by December, in hopes that the vaccine will be effective.
Some nine thousand people have volunteered for Phase 3 trials in Brazil. The results should be known in October.
If positive, the government of São Paulo expects to initiate . . .